Babita Deka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Babita Deka has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Bhargab Jyoti Sahariah
NETES Institute of Pharmaceutical Science
4 shared publications - Pooja Patowary
NETES Institute of Pharmaceutical Science, NEMCARE Group of Institutions
4 shared publications - Apurba Talukdar
NETES Institute of Pharmaceutical Science, NEMCARE Group of Institutions
3 shared publications Apurba Talukdar
Department of Pharmaceutical Chemistry, NETES Institute of Pharmaceutical Science, NEMCARE Group of Institutions,Mirza, Kamrup, Shantipur, Assam, PIN - 781125, India
2 shared publicationsBhargab Jyoti Sahariah
Department of Pharmaceutical Chemistry, NETES Institute of Pharmaceutical Science, NEMCARE Group of Institutions,Mirza, Kamrup, Shantipur, Assam, PIN - 781125, India
2 shared publications- Debaprotim Dasgupta
NETES Institute of Pharmaceutical Science, NEMCARE Group of Institutions
2 shared publications
Latest Publications
- 19 September 2026
- Published by Ankara Universitesi Eczacilik Fakultesi Dergisi in Ankara Universitesi Eczacilik Fakultesi Dergisi
- Vol. 50 (3) , 750-771
A THERAPEUTIC INSIGHTS ON EMERGING INDOLE-3-ACETIC ACID DERIVATIVES
Objective: Auxin or indole-3-acetic acid (IAA) is a pivotal phytohormone that regulates plant growth, development, and environmental responses Indole-3-acetic acid (IAA), a small molecule originated early in evolution in organisms like blue-green algae (cyanobacteria). Structurally, IAA consists of a carboxylic side chain and an indole ring. IAA exhibits unique biological behaviors such as dimer formation stabilized by hydrogen bonding. It is synthesized by plants and certain bacteria including Pseudomonas, Rhizobium and Azospirillum, through complex, redundant biosynthetic pathways involving multiple intermediates and enzymes. These pathways demonstrate robustness and adapt ability, enabling compensation for disruptions. The indole-3-acetic acid derivatives were designed and studied numerously for their wide array of pharmacological actions. Therefore, derivatives of this moiety need to be studied for the identification of their diverse pharmacological actions, which will help the future medicinal chemists to a larger extent.Result and Discussion: In this review study, the different derivatives of Indole-3-acetic acid were studied. The study highlights the synthetic and medicinal potential of indole-3-acetic acid and its indole-based analogues, exploring their role in advancing therapeutic and biological applications.
- 19 September 2026
- Published by Ankara Universitesi Eczacilik Fakultesi Dergisi in Ankara Universitesi Eczacilik Fakultesi Dergisi
- Vol. 50 (3) , 750-771
A THERAPEUTIC INSIGHTS ON EMERGING INDOLE-3-ACETIC ACID DERIVATIVES
Objective: Auxin or indole-3-acetic acid (IAA) is a pivotal phytohormone that regulates plant growth, development, and environmental responses Indole-3-acetic acid (IAA), a small molecule originated early in evolution in organisms like blue-green algae (cyanobacteria). Structurally, IAA consists of a carboxylic side chain and an indole ring. IAA exhibits unique biological behaviors such as dimer formation stabilized by hydrogen bonding. It is synthesized by plants and certain bacteria including Pseudomonas, Rhizobium and Azospirillum, through complex, redundant biosynthetic pathways involving multiple intermediates and enzymes. These pathways demonstrate robustness and adapt ability, enabling compensation for disruptions. The indole-3-acetic acid derivatives were designed and studied numerously for their wide array of pharmacological actions. Therefore, derivatives of this moiety need to be studied for the identification of their diverse pharmacological actions, which will help the future medicinal chemists to a larger extent.Result and Discussion: In this review study, the different derivatives of Indole-3-acetic acid were studied. The study highlights the synthetic and medicinal potential of indole-3-acetic acid and its indole-based analogues, exploring their role in advancing therapeutic and biological applications.
- 8 December 2025
- Published by Springer Nature in Chemical Papers
- Vol. 80 (3) , 2627-2645
Design, synthesis, molecular dynamics and in silico pharmacokinetic study of N-(4-(thiazol-2-ylamino)phenyl)benzamide analogues as promising anti-inflammatory agents
- 8 December 2025
- Published by Springer Nature in Chemical Papers
- Vol. 80 (3) , 2627-2645
Design, synthesis, molecular dynamics and in silico pharmacokinetic study of N-(4-(thiazol-2-ylamino)phenyl)benzamide analogues as promising anti-inflammatory agents
- 1 October 2025
- Published by Bentham Science Publishers Ltd. in Current Enzyme Inhibition
- Vol. 21 (3) , 209-221
Design, Synthesis and Preliminary Assessment of Novel Cytotoxic Xanthone-Based Derivatives Targeting Human DNA Topoisomerase IIα
Background: Xanthones, also known as dibenzo-γ-pyrone or 9H-xanthen-9-ones, constitute an essential group of oxygenated heterocycles that possess a dibenzo-pyrone structure having the chemical formula C13H8O2. These compounds have generated significant interest due to their high taxonomic relevance and pharmacological characteristics. Xanthone and its derivatives are cytotoxic medications due to their planar structure and capacity to intercalate with Deoxyribonucleic acid (DNA). As a DNA intercalator, xanthone extraction and synthesis have become popular in cytotoxic research. Objective: Our study aimed to synthesize new xanthone derivatives and evaluate their anticancer efficacy. Methods: We developed a series of novel xanthone derivatives via conventional synthesis and We then assessed their anticancer efficacy against the A549 human lung cancer cell line utilizing the MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Furthermore, we conducted a docking study using a receptor with the Protein Data Bank (PDB) ID: IZXM to validate the anticancer activity of the synthesized compounds in silico. Results: Drug likeliness and molecular docking studies confirmed the biopotential and anticancer effectiveness of novel human DNA topoisomerase IIα inhibitors. Our in vitro anticancer activity results indicated that synthesized compound 5a had the lowest half-maximal inhibitory concentration (IC50) value and a higher cytotoxicity activity. Conclusion: The study concluded that synthesizing new xanthone derivatives and evaluating their cytotoxic activity showed promising potency in compound 5a as an anticancer candidate. The synthesized compounds have silico drug-relevant properties, which ensure their potential leads for future drug discovery studies.
- 1 October 2025
- Published by Bentham Science Publishers Ltd. in Current Enzyme Inhibition
- Vol. 21 (3) , 209-221
Design, Synthesis and Preliminary Assessment of Novel Cytotoxic Xanthone-Based Derivatives Targeting Human DNA Topoisomerase IIα
Background: Xanthones, also known as dibenzo-γ-pyrone or 9H-xanthen-9-ones, constitute an essential group of oxygenated heterocycles that possess a dibenzo-pyrone structure having the chemical formula C13H8O2. These compounds have generated significant interest due to their high taxonomic relevance and pharmacological characteristics. Xanthone and its derivatives are cytotoxic medications due to their planar structure and capacity to intercalate with Deoxyribonucleic acid (DNA). As a DNA intercalator, xanthone extraction and synthesis have become popular in cytotoxic research. Objective: Our study aimed to synthesize new xanthone derivatives and evaluate their anticancer efficacy. Methods: We developed a series of novel xanthone derivatives via conventional synthesis and We then assessed their anticancer efficacy against the A549 human lung cancer cell line utilizing the MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Furthermore, we conducted a docking study using a receptor with the Protein Data Bank (PDB) ID: IZXM to validate the anticancer activity of the synthesized compounds in silico. Results: Drug likeliness and molecular docking studies confirmed the biopotential and anticancer effectiveness of novel human DNA topoisomerase IIα inhibitors. Our in vitro anticancer activity results indicated that synthesized compound 5a had the lowest half-maximal inhibitory concentration (IC50) value and a higher cytotoxicity activity. Conclusion: The study concluded that synthesizing new xanthone derivatives and evaluating their cytotoxic activity showed promising potency in compound 5a as an anticancer candidate. The synthesized compounds have silico drug-relevant properties, which ensure their potential leads for future drug discovery studies.
- 14 August 2025
- Published by Elsevier in Journal of the Indian Chemical Society
- Vol. 102 (10)
Coumarin-indole hybrids: synthesis, characterization & anti-inflammatory evaluation
- 14 August 2025
- Published by Elsevier in Journal of the Indian Chemical Society
- Vol. 102 (10)
Coumarin-indole hybrids: synthesis, characterization & anti-inflammatory evaluation
- 28 May 2025
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 119, 108523
Design and synthesis of novel xanthone-thiazole hybrid derivatives as potent anti-inflammatory agent
- 28 May 2025
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 119, 108523
Design and synthesis of novel xanthone-thiazole hybrid derivatives as potent anti-inflammatory agent
- 2 August 2024
- Published by Springer Nature in Chemical Papers
- Vol. 78 (13) , 7313-7333
Exploring synthetic xanthone derivatives as potential anti-inflammatory agents: a comprehensive review
- 2 August 2024
- Published by Springer Nature in Chemical Papers
- Vol. 78 (13) , 7313-7333
Exploring synthetic xanthone derivatives as potential anti-inflammatory agents: a comprehensive review